# Agilent Technologies, Inc.: financial statements, quarterly

A · NYSE · CIK 1090872 · [Technology](/sectors/technology.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/a.md) · [Financials](/companies/a/financials.md) · [Filings](/companies/a/filings.md) · [Insiders](/companies/a/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/a/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,688 d](/filings/0001090872-25-000087.md) | [1,658](/filings/0001090872-25-000008.md) | [1,573](/filings/0001090872-25-000021.md) | [1,578](/filings/0001090872-25-000036.md) | [1,701 d](/filings/0001090872-25-000087.md) | [1,681](/filings/0001090872-26-000023.md) | [1,668](/filings/0001090872-26-000055.md) | [1,738](/filings/0001090872-26-000064.md) | [1,861 d](/filings/0001090872-25-000087.md) | [1,798](/filings/0001090872-26-000023.md) | [1,835](/filings/0001090872-26-000055.md) | [1,878](/filings/0001090872-26-000064.md) |
| Cost of revenue | $m | [773 d](/filings/0001090872-25-000087.md) | [750](/filings/0001090872-25-000008.md) | [717](/filings/0001090872-25-000021.md) | [723](/filings/0001090872-25-000036.md) | [785 d](/filings/0001090872-25-000087.md) | [782](/filings/0001090872-26-000023.md) | [802](/filings/0001090872-26-000055.md) | [850](/filings/0001090872-26-000064.md) | [871 d](/filings/0001090872-25-000087.md) | [852](/filings/0001090872-26-000023.md) | [845](/filings/0001090872-26-000055.md) | [836](/filings/0001090872-26-000064.md) |
| Research and development | $m | [114 d](/filings/0001090872-25-000087.md) | [128](/filings/0001090872-25-000008.md) | [113](/filings/0001090872-25-000021.md) | [127](/filings/0001090872-25-000036.md) | [111 d](/filings/0001090872-25-000087.md) | [113](/filings/0001090872-26-000023.md) | [112](/filings/0001090872-26-000055.md) | [111](/filings/0001090872-26-000064.md) | [119 d](/filings/0001090872-25-000087.md) | [117](/filings/0001090872-26-000023.md) | [126](/filings/0001090872-26-000055.md) | [123](/filings/0001090872-26-000064.md) |
| Selling, general and administrative | $m | [393 d](/filings/0001090872-25-000087.md) | [396](/filings/0001090872-25-000008.md) | [380](/filings/0001090872-25-000021.md) | [395](/filings/0001090872-25-000036.md) | [397 d](/filings/0001090872-25-000087.md) | [410](/filings/0001090872-26-000023.md) | [454](/filings/0001090872-26-000055.md) | [417](/filings/0001090872-26-000064.md) | [428 d](/filings/0001090872-25-000087.md) | [476](/filings/0001090872-26-000023.md) | [465](/filings/0001090872-26-000055.md) | [475](/filings/0001090872-26-000064.md) |
| Operating income | $m | [408 d](/filings/0001090872-25-000087.md) | [384](/filings/0001090872-25-000008.md) | [363](/filings/0001090872-25-000021.md) | [333](/filings/0001090872-25-000036.md) | [408 d](/filings/0001090872-25-000087.md) | [376](/filings/0001090872-26-000023.md) | [300](/filings/0001090872-26-000055.md) | [360](/filings/0001090872-26-000064.md) | [443 d](/filings/0001090872-25-000087.md) | [353](/filings/0001090872-26-000023.md) | [399](/filings/0001090872-26-000055.md) | [444](/filings/0001090872-26-000064.md) |
| Interest expense | $m | [22.0 d](/filings/0001090872-25-000087.md) | [22.0](/filings/0001090872-25-000008.md) | [20.0](/filings/0001090872-25-000021.md) | [22.0](/filings/0001090872-25-000036.md) | [32.0 d](/filings/0001090872-25-000087.md) | [28.0](/filings/0001090872-26-000023.md) | [29.0](/filings/0001090872-26-000055.md) | [28.0](/filings/0001090872-26-000064.md) | [27.0 d](/filings/0001090872-25-000087.md) | [25.0](/filings/0001090872-26-000023.md) | [25.0](/filings/0001090872-26-000055.md) | [29.0](/filings/0001090872-26-000064.md) |
| Income tax | $m | [(55.0) d](/filings/0001090872-25-000087.md) | [55.0](/filings/0001090872-25-000008.md) | [66.0](/filings/0001090872-25-000021.md) | [61.0](/filings/0001090872-25-000036.md) | [50.0 d](/filings/0001090872-25-000087.md) | [49.0](/filings/0001090872-26-000023.md) | [45.0](/filings/0001090872-26-000055.md) | [30.0](/filings/0001090872-26-000064.md) | [8.0 d](/filings/0001090872-25-000087.md) | [59.0](/filings/0001090872-26-000023.md) | [69.0](/filings/0001090872-26-000055.md) | [82.0](/filings/0001090872-26-000064.md) |
| Net income | $m | [475 d](/filings/0001090872-25-000087.md) | [348](/filings/0001090872-25-000008.md) | [308](/filings/0001090872-25-000021.md) | [282](/filings/0001090872-25-000036.md) | [351 d](/filings/0001090872-25-000087.md) | [318](/filings/0001090872-26-000023.md) | [215](/filings/0001090872-26-000055.md) | [336](/filings/0001090872-26-000064.md) | [434 d](/filings/0001090872-25-000087.md) | [305](/filings/0001090872-26-000023.md) | [339](/filings/0001090872-26-000055.md) | [362](/filings/0001090872-26-000064.md) |
| Diluted EPS | $ per share | not reported | [1.18](/filings/0001090872-25-000008.md) | [1.05](/filings/0001090872-25-000021.md) | [0.97](/filings/0001090872-25-000036.md) | not reported | [1.11](/filings/0001090872-26-000023.md) | [0.75](/filings/0001090872-26-000055.md) | [1.18](/filings/0001090872-26-000064.md) | not reported | [1.07](/filings/0001090872-26-000023.md) | [1.20](/filings/0001090872-26-000055.md) | [1.28](/filings/0001090872-26-000064.md) |
| Basic EPS | $ per share | not reported | [1.19](/filings/0001090872-25-000008.md) | [1.05](/filings/0001090872-25-000021.md) | [0.97](/filings/0001090872-25-000036.md) | not reported | [1.12](/filings/0001090872-26-000023.md) | [0.75](/filings/0001090872-26-000055.md) | [1.18](/filings/0001090872-26-000064.md) | not reported | [1.08](/filings/0001090872-26-000023.md) | [1.20](/filings/0001090872-26-000055.md) | [1.28](/filings/0001090872-26-000064.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.6](/filings/0001090872-25-000087.md) | [1.7](/filings/0001090872-24-000011.md) | [1.7](/filings/0001090872-24-000021.md) | [1.8](/filings/0001090872-24-000033.md) | [1.3](/filings/0001090872-25-000087.md) | [1.5](/filings/0001090872-25-000008.md) | [1.5](/filings/0001090872-25-000021.md) | [1.5](/filings/0001090872-25-000036.md) | [1.8](/filings/0001090872-26-000064.md) | [1.8](/filings/0001090872-26-000023.md) | [1.8](/filings/0001090872-26-000055.md) | [1.8](/filings/0001090872-26-000064.md) |
| Current assets | $bn | [4.2](/filings/0001090872-24-000049.md) | [4.3](/filings/0001090872-24-000011.md) | [4.2](/filings/0001090872-24-000021.md) | [4.3](/filings/0001090872-24-000033.md) | [4.0](/filings/0001090872-25-000087.md) | [4.1](/filings/0001090872-25-000008.md) | [4.2](/filings/0001090872-25-000021.md) | [4.3](/filings/0001090872-25-000036.md) | [4.6](/filings/0001090872-26-000064.md) | [4.6](/filings/0001090872-26-000023.md) | [4.8](/filings/0001090872-26-000055.md) | [4.7](/filings/0001090872-26-000064.md) |
| Total assets | $bn | [10.8](/filings/0001090872-24-000049.md) | [10.9](/filings/0001090872-24-000011.md) | [10.9](/filings/0001090872-24-000021.md) | [11.0](/filings/0001090872-24-000033.md) | [11.8](/filings/0001090872-25-000087.md) | [11.9](/filings/0001090872-25-000008.md) | [12.2](/filings/0001090872-25-000021.md) | [12.2](/filings/0001090872-25-000036.md) | [12.7](/filings/0001090872-26-000064.md) | [12.8](/filings/0001090872-26-000023.md) | [13.1](/filings/0001090872-26-000055.md) | [14.0](/filings/0001090872-26-000064.md) |
| Current liabilities | $bn | [1.6](/filings/0001090872-24-000049.md) | [1.6](/filings/0001090872-24-000011.md) | [2.0](/filings/0001090872-24-000021.md) | [2.4](/filings/0001090872-24-000033.md) | [1.9](/filings/0001090872-25-000087.md) | [1.9](/filings/0001090872-25-000008.md) | [2.0](/filings/0001090872-25-000021.md) | [1.9](/filings/0001090872-25-000036.md) | [2.3](/filings/0001090872-26-000064.md) | [2.2](/filings/0001090872-26-000023.md) | [2.3](/filings/0001090872-26-000055.md) | [2.3](/filings/0001090872-26-000064.md) |
| Total liabilities | $bn | [4.9](/filings/0001090872-24-000049.md) | [4.8](/filings/0001090872-24-000011.md) | [4.6](/filings/0001090872-24-000021.md) | [5.1](/filings/0001090872-24-000033.md) | [5.9](/filings/0001090872-25-000087.md) | [5.9](/filings/0001090872-25-000008.md) | [6.0](/filings/0001090872-25-000021.md) | [5.9](/filings/0001090872-25-000036.md) | [6.0](/filings/0001090872-26-000064.md) | [5.9](/filings/0001090872-26-000023.md) | [5.9](/filings/0001090872-26-000055.md) | [6.6](/filings/0001090872-26-000064.md) |
| Long-term debt | $bn | [2.7](/filings/0001090872-24-000049.md) | [2.6](/filings/0001090872-24-000011.md) | [2.1](/filings/0001090872-24-000021.md) | [2.1](/filings/0001090872-24-000033.md) | [3.3](/filings/0001090872-25-000087.md) | [3.3](/filings/0001090872-25-000008.md) | [3.3](/filings/0001090872-25-000021.md) | [3.4](/filings/0001090872-25-000036.md) | [3.1](/filings/0001090872-26-000064.md) | [3.1](/filings/0001090872-26-000023.md) | [3.1](/filings/0001090872-26-000055.md) | [3.6](/filings/0001090872-26-000064.md) |
| Short-term borrowings | $bn | [0.0](/filings/0001090872-24-000049.md) | not reported | [0.4](/filings/0001090872-24-000021.md) | [0.8](/filings/0001090872-24-000033.md) | [0.0](/filings/0001090872-25-000087.md) | [0.0](/filings/0001090872-25-000008.md) | [0.1](/filings/0001090872-25-000021.md) | [0.1](/filings/0001090872-25-000036.md) | [0.3](/filings/0001090872-26-000064.md) | [0.3](/filings/0001090872-26-000023.md) | [0.3](/filings/0001090872-26-000055.md) | [0.3](/filings/0001090872-26-000064.md) |
| Shareholders' equity | $bn | [5.8](/filings/0001090872-24-000049.md) | [6.2](/filings/0001090872-24-000011.md) | [6.2](/filings/0001090872-24-000021.md) | [5.9](/filings/0001090872-24-000033.md) | [5.9](/filings/0001090872-25-000087.md) | [6.0](/filings/0001090872-25-000008.md) | [6.1](/filings/0001090872-25-000021.md) | [6.4](/filings/0001090872-25-000036.md) | [6.7](/filings/0001090872-26-000064.md) | [6.9](/filings/0001090872-26-000023.md) | [7.1](/filings/0001090872-26-000055.md) | [7.4](/filings/0001090872-26-000064.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [516 d](/filings/0001090872-25-000087.md) | [485](/filings/0001090872-25-000008.md) | [333 d](/filings/0001090872-25-000021.md) | [452 d](/filings/0001090872-25-000036.md) | [481 d](/filings/0001090872-25-000087.md) | [431](/filings/0001090872-26-000023.md) | [221 d](/filings/0001090872-26-000055.md) | [362 d](/filings/0001090872-26-000064.md) | [545 d](/filings/0001090872-25-000087.md) | [268](/filings/0001090872-26-000023.md) | [277 d](/filings/0001090872-26-000055.md) | [519 d](/filings/0001090872-26-000064.md) |
| Capital expenditure | $m | [84.0 d](/filings/0001090872-25-000087.md) | [90.0](/filings/0001090872-25-000008.md) | [103 d](/filings/0001090872-25-000021.md) | [92.0 d](/filings/0001090872-25-000036.md) | [93.0 d](/filings/0001090872-25-000087.md) | [97.0](/filings/0001090872-26-000023.md) | [114 d](/filings/0001090872-26-000055.md) | [103 d](/filings/0001090872-26-000064.md) | [93.0 d](/filings/0001090872-25-000087.md) | [93.0](/filings/0001090872-26-000023.md) | [76.0 d](/filings/0001090872-26-000055.md) | [80.0 d](/filings/0001090872-26-000064.md) |
| Dividends paid | $m | [66.0 d](/filings/0001090872-25-000087.md) | [69.0](/filings/0001090872-25-000008.md) | [69.0](/filings/0001090872-25-000021.md) | [68.0](/filings/0001090872-25-000036.md) | [68.0 d](/filings/0001090872-25-000087.md) | [71.0](/filings/0001090872-26-000023.md) | [70.0](/filings/0001090872-26-000055.md) | [71.0](/filings/0001090872-26-000064.md) | [70.0 d](/filings/0001090872-25-000087.md) | [72.0](/filings/0001090872-26-000023.md) | [72.0](/filings/0001090872-26-000055.md) | [72.0](/filings/0001090872-26-000064.md) |
| Share repurchases | $m | [80.0 d](/filings/0001090872-25-000087.md) | [0.0](/filings/0001090872-25-000008.md) | [230 d](/filings/0001090872-25-000021.md) | [585 d](/filings/0001090872-25-000036.md) | [335 d](/filings/0001090872-25-000087.md) | [90.0](/filings/0001090872-26-000023.md) | [165 d](/filings/0001090872-26-000055.md) | [85.0 d](/filings/0001090872-26-000064.md) | [85.0 d](/filings/0001090872-25-000087.md) | [152](/filings/0001090872-26-000023.md) | [65.0 d](/filings/0001090872-26-000055.md) | [78.0 d](/filings/0001090872-26-000064.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-01-31) | Q2 FY2023 (2023-04-30) | Q3 FY2023 (2023-07-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [297](/filings/0001090872-24-000011.md) | [297](/filings/0001090872-24-000021.md) | [295](/filings/0001090872-24-000033.md) | [294](/filings/0001090872-25-000008.md) | [293](/filings/0001090872-25-000021.md) | [291](/filings/0001090872-25-000036.md) | [287](/filings/0001090872-26-000023.md) | [285](/filings/0001090872-26-000055.md) | [285](/filings/0001090872-26-000064.md) | [284](/filings/0001090872-26-000023.md) | [283](/filings/0001090872-26-000055.md) | [283](/filings/0001090872-26-000064.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 281,928,854 at 2026-08-26, from the cover of the [10-Q filed 2026-09-01](/filings/0001090872-26-000064.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.